Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Sepsis Early Prediction Technology

Project description

New system for sepsis rapid diagnosis

Sepsis and septic shock are critical conditions caused by an immune response to infection, causing up to 11 million deaths annually. Timely treatment is vital. However, current diagnostics are inadequate as they require faster tools and effective treatments to improve survival rates. The EIC-funded SepTech project is developing a rapid diagnostic system that identifies pathogens and their antimicrobial resistance much more quickly than current clinical procedures, reducing the time to administer the right antimicrobial treatment. After developing the prototype, the project will test it using specimens from hospitalised septic patients and compare the results with standard procedures. It will also prepare the system for market entry, a funding round and the start of commercialisation of the device.

Objective

Sepsis and septic shock are life-threatening conditions caused by a dysregulated immune response to an infection with a high mortality rate of up to 25%. According to WHO, there are approximately 11 million sepsis-related deaths worldwide annually, representing about 20% of all global deaths. A timely and accurate treatment is critical since delays in administration of an effective antimicrobial therapy increases mortality by 10% with every hour. Unfortunately, current diagnostic approaches – the gold standard being blood culture – are inadequate for addressing this issue. For these reasons, there is a critical need for faster diagnostic tools and identification of the best treatment strategies, capable of providing an accurate classification of the sepsis to improve the overall survival of the patients.
The project SEPTech intends to address and solve these problems with: a) design and prototype a system allowing a rapid diagnostic process - significantly faster than the actual clinical standard procedures – for the identification of the causing pathogens and antimicrobial resistance to strongly reduce the time for the administration of the most appropriate antimicrobial treatment; b) test the prototype using real world specimens from hospitalised septic patients against gold standard procedures; c) set the ground for go-to-market via a special purpose vehicle and d) prepare for a round of funding by private and public investors to obtain IVD CE mark and start commercialising the device.

Fields of science (EuroSciVoc)

This project has not yet been classified with EuroSciVoc.
Be the first one to suggest relevant scientific fields and help us improve our classification service

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC - HORIZON EIC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2025-TRANSITIONOPEN

See all projects funded under this call

Coordinator

UNIVERSITAETSKLINIKUM FREIBURG
Net EU contribution
€ 673 076,70
Address
HUGSTETTER STRASSE 49
79106 Freiburg
Germany
Region
Baden-Württemberg Freiburg Freiburg im Breisgau, Stadtkreis
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Participants (3)